A patient presents with Endocrinopathy, fibrous dysplasia of bone and hyperpigmentation. Diagnosis is?
**Core Concept:**
Fibrous dysplasia is a benign bone disorder characterized by abnormal bone formation and replacement of normal bone tissue with fibrous connective tissue. It can lead to endocrinopathies and hyperpigmentation due to its effects on hormone production and functioning.
**Why the Correct Answer is Right:**
The correct answer, option D, is McCune-Albright syndrome. This is a rare disorder that results from a genetic mutation involving the GNAS gene, leading to fibrous dysplasia, endocrine dysfunction, and hyperpigmentation. The endocrinopathies often present as primary hyperparathyroidism (option D).
**Why Each Wrong Option is Incorrect:**
Option A (McCune-Albright-related polyostotic fibrous dysplasia) and option B (polyostotic fibrous dysplasia) are related conditions but do not encompass all symptoms, including endocrine dysfunction and hyperpigmentation. Option C (fibrous dysplasia without endocrine involvement) does not address the endocrinopathies and hyperpigmentation present in the patient's symptoms.
**Why the Correct Answer is Right:**
In McCune-Albright syndrome, the genetic mutation affects the GNAS gene, leading to fibrous dysplasia, endocrine dysfunction, and hyperpigmentation. The endocrine dysfunction is often characterized by primary hyperparathyroidism, which presents with symptoms like renal stones, renal insufficiency, osteoporosis, and hypercalcemia.
**Why Each Wrong Option is Incorrect:**
Option A (McCune-Albright-related polyostotic fibrous dysplasia) and option B (polyostotic fibrous dysplasia) address fibrous dysplasia but do not encompass the endocrine dysfunction and hyperpigmentation. Option C (fibrous dysplasia without endocrine involvement) does not address the endocrinopathies and hyperpigmentation present in the patient's symptoms.
**Clinical Pearl:**
McCune-Albright syndrome is a rare genetic disorder that can be diagnosed through genetic testing. Treatment focuses on addressing the specific endocrinopathies and managing complications like renal stones and osteoporosis. Close monitoring of calcium and parathyroid hormone levels is crucial for managing the patient effectively.